BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5483974)

  • 1. [Histochemical studies on fibrinolytic activity of experimental thrombi in rats after administration of direct and indirect fibrinolytic agents].
    Denk H; Fischer M
    Thromb Diath Haemorrh; 1970 Oct; 24(1):48-54. PubMed ID: 5483974
    [No Abstract]   [Full Text] [Related]  

  • 2. On thrombosis, thrombolysis and fibrinolysis. I. Thrombolytic therapy of deep venous thrombosis. II. Assay of individual fibrinolytic response.
    Robertson BR
    Acta Chir Scand Suppl; 1971; 421():1-51. PubMed ID: 5292287
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.
    Hirsh J; Buchanan M; Glynn MF; Mustard JF
    J Lab Clin Med; 1968 Aug; 72(2):245-55. PubMed ID: 5671200
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on fluidity of blood on the basis of fibrinolysis. 8. Analysis of fibrinolytic activity of the human blood activated with streptokinase and urokinase in vitro--with special reference to its similarity to fibrinolytic activity of fluid corpse blood.
    Ishizu H; Nobuhara M; Takata H
    Nihon Hoigaku Zasshi; 1971 Sep; 25(3):366-72. PubMed ID: 5167453
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current state of anticoagulant and fibrinolytic therapy].
    Hladovec J
    Cas Lek Cesk; 1971 Oct; 110(42):969-75. PubMed ID: 5114558
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasoactive drugs and cerebral circulation].
    Pratesi F; Corsi C; Tesi M; Spinelli P; Brunetti S; Caramelli L
    Minerva Med; 1968 Dec; 59(96):5207-17. PubMed ID: 4974813
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
    Frick G; Frick U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):389-403. PubMed ID: 4168276
    [No Abstract]   [Full Text] [Related]  

  • 8. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical basis for the control of anticoagulant and thrombolytic therapy].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):116-28. PubMed ID: 4098766
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombolysis in vitro. II. Thrombolytic effect of streptokinase and urokinase in health and disease.
    Jacobsen CD; Chandler AB
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:225+. PubMed ID: 5862559
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antirheumatics with fibrinolytic properties. Comparison between compounds of the flufenamic acid series with trifluoromethyl analogues of azapropazone].
    Wagner-Jauregg T; Jahn U; Bürlimann W
    Arzneimittelforschung; 1973 Jul; 23(7):911-3. PubMed ID: 4800442
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the quality and quantity of therapeutic (equal frontal, equal external) fibrinolysis in the thrombelastograph].
    Fischbacher W
    Klin Wochenschr; 1968 Sep; 46(18):1000-3. PubMed ID: 4235179
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of thrombophilic states by prolonged activation of fibrinolysis].
    De Nicola P
    Rev Atheroscler (Paris); 1967; 9(3):20-2. PubMed ID: 4174225
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinase-induced thrombolysis in the rabbit.
    Herbert JM; Bernat A; Sainte-Marie M; Dol F; Rinaldi M
    Thromb Haemost; 1993 Mar; 69(3):268-71. PubMed ID: 8470050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The behavior of plasmitic fibrinogenolytic and fibrinolytic activities after activation with streptokinase and urokinase].
    Ferrauto A; Cristaldi R; Terranova R; Giuffrida G
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1483-6. PubMed ID: 5878159
    [No Abstract]   [Full Text] [Related]  

  • 17. [Animal experimental studies on the thrombolytic effect of streptokinase].
    Markwardt F; Klöcking HP; Sedlarik K; Perlewitz J; Drawert J; Hoffmann J
    Acta Biol Med Ger; 1976; 35(2):193-203. PubMed ID: 998115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The behavior of plasmatic fibrinogenolytic activity after activation with streptokinase and urokinase in presence of epsilon amino-caproic acid and of the parotid inhibitor of trypsin].
    Ferrauto A; Cristaldi R; Terranova R; Giuffrida G
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1486-7. PubMed ID: 5298373
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action mechanism of nicotinic acid on fibrinolysis in vitro and in vivo].
    Andreenko GV; Migalina LA
    Vopr Med Khim; 1971; 17(4):423-7. PubMed ID: 5317629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On intraocular fibrinolysis.
    Pandolfi M; Nilsson IM; Niléhn JE
    Thromb Diath Haemorrh; 1966 Jan; 15(1):161-72. PubMed ID: 5919798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.